Covid-19 patients being treated with FDA-recognized drugs

Covid-19 patients being treated with FDA-recognized drugs
Published 7 October 2020
Ei Thinzar Kyaw

Covid-19 patients have been receiving treatment with drugs recognized by the Food and Drug Administration (FDA) for over a week, said Professor Dr Zaw Wai Soe, vice chairman of Yangon Region Covid-19 Prevention, Control and Treatment Coordination Committee.

“When it comes to treatment, we are treating all the Covid-19 patients—those showing symptoms, asymptomatic ones, feverish ones and those with serious illness—with FDA drugs in accord with the international standards. We have used these drugs for over a week,” the professor said.

State Counsellor Daw Aung San Suu Kyi on October 5 met with Indian Army Chief General MM Naravane at the Ministry of Foreign Affairs in Nay Pyi Taw, according to the announcement from the Indian Embassy.

The announcement reported that both sides discussed important bilateral issues.  The Indian delegation also handed over a consignment of over 3,000 vials of the drug Remdesivir to Myanmar as a part of India’s assistance in fighting against the ongoing COVID-19 outbreak in Myanmar.

In order to ensure continued supply chain of medicines and medical equipment at hospitals, they are being purchased with the emergency fund and CERP fund of over Ks36,000 million. Medicines and medical equipment related to Covid-19 are arriving in batches, according to the Ministry of Health and Sports. 

Moreover, international organizations and foreign countries are providing cash assistance and necessary medical equipment such as US$10 million by GAVI, US$7 million by Global Fund, US$16 million by Access to Health Fund, US$5 million by WHO, US$8 million by USAID, US$8 million by World Bank, US$27 million by Japan, US$1 million by the Republic of Korea and US$300,000 by Thailand. There are also additional funds of Ks267 billion by the government and medical supplies donated by public well-wishers.